Australians have understandable reasons for favouring domestic shares. Local companies are familiar, dividends can carry franking credits and the market has produced many successful businesses. But familiarity can disguise concentration. At 30 June 2026, MSCI Australia had 40.8% in financials and 24.5% in materials. Nearly two-thirds of the index was therefore tied to two sectors.
By contrast, the MSCI All Country World Index contained 2,461 companies across 23 developed and 24 emerging markets, covering about 85% of the global investable equity opportunity set. This is not an argument against Australian shares. It is an argument against expecting one relatively narrow market to provide every source of growth, innovation and diversification an investor needs.
Global should be structural, not tactical
A global allocation gives investors access to sectors that are scarce in Australia, including semiconductors, software, medical technology, aerospace, luxury goods and industrial automation. It also spreads exposure across different economies, currencies and revenue pools. Currency and geopolitical risks do not disappear, but dependence on the Australian economy, banks and commodity cycle is reduced.
Trying to identify the country that will lead the market next year is rarely a durable strategy. A better starting point is to treat global equities as a long-term portfolio allocation, then search across countries for businesses where quality, price and a catalyst overlap.
Quality is more than a high return on equity
A quality company should pass several connected tests:
It solves an important problem and has an advantage that competitors cannot readily copy, such as intellectual property, network effects, switching costs, scale or trusted distribution.
It converts accounting profit into cash and can reinvest at attractive returns, rather than relying on acquisitions or ever-rising debt.
Its balance sheet can withstand a difficult cycle, while management allocates capital sensibly among investment, acquisitions, dividends, buybacks and debt reduction.
Its incentives are aligned with shareholders and the investment case does not depend on a single optimistic forecast.
The most valuable quality is often the ability to reinvest. A company earning attractive returns today but lacking reinvestment opportunities may be a sound business, yet a slower compounder. Conversely, growth that consumes large amounts of capital or dilutes shareholders can destroy value even when revenue rises quickly.
A good company is not automatically a good investment
Investment success depends not only on what a business becomes, but on what the purchase price already assumes. A wonderful company can disappoint when its valuation requires flawless execution. A merely good company can outperform when expectations are too pessimistic and its economics improve.
Rather than asking whether a share looks cheap against its own history, investors should ask what growth, margins and reinvestment returns are embedded in the price. The thesis should work under a reasonable base case, offer meaningful upside if management executes and preserve capital if events are less favourable. Valuation is not a timing tool, but it determines the margin for error.
A catalyst can turn value into a result
Cheap shares sometimes remain cheap because nothing changes. A credible catalyst gives the market a reason to reassess the company. It may be a new product cycle, margin recovery, balance-sheet repair, an asset sale, a management change or a different approach to capital allocation.
In our research, event-driven situations are especially useful hunting grounds because a defined change can disrupt routine valuation and create a new information set. These situations can include restructurings, asset sales, management changes, balance-sheet repair, index changes or a shift in capital allocation. Temporary uncertainty or forced changes in ownership can create mispricing. However, an event alone does not create value. Investors still need to examine the underlying business, balance sheet, management's ability to execute and the downside if the expected change is delayed or fails to occur.
Before buying, it helps to write the thesis in plain language, identify two or three operating measures that must improve and specify what evidence would disprove the case. A successful investment process needs an explicit sell discipline as much as an attractive entry point.
Where quality and value overlap
The United States remains the deepest market for technology, healthcare and specialised industrial companies, but it is not uniformly attractive. At 30 June, the MSCI USA Index traded at 21.0 times forward earnings, compared with 15.6 times for the MSCI World ex USA Index. That gap is not a forecast that America must underperform. It simply means expectations are higher and selectivity matters. Opportunities exist beyond the largest technology platforms in the infrastructure enabling computing and electrification, specialised healthcare and companies undergoing credible strategic change.
Japan offers precision manufacturing, automation, semiconductor equipment and strong consumer franchises. Corporate reform is also a genuine catalyst. The Tokyo Stock Exchange's updated 2026 initiative continues to press listed companies to focus on cost of capital and the appropriate allocation of resources. Reform can unlock value through better disclosure, asset sales and capital returns, although it is not a substitute for a sound business.
Europe contains world-class aerospace, industrial automation, testing, healthcare and semiconductor businesses, often with global revenues. Emerging Asia offers critical parts of the semiconductor and electronics supply chain. Both regions can provide lower starting valuations than the most crowded US shares, but investors must allow for cyclical earnings, governance, regulation and geopolitical risk. The best opportunity is usually a company with global economics and a locally overlooked valuation, not a blanket bet on a flag.
How fund managers can fit
A low-cost global index fund is a rational core holding for many investors. An active manager should have a clear job around that core: finding less-researched companies and corporate events, reducing exposure to expensive index concentrations, or pursuing a genuinely differentiated style. A manager who simply owns the same dominant companies as the index needs to justify the additional fee.
Manager selection should focus on whether the edge is understandable and repeatable, how the portfolio differs from its benchmark, the sources of risk, capacity, fees and the strength of the operating platform. Recent performance alone is insufficient. A concentrated or emerging manager may be best sized as a satellite while its longer-term record and business resilience develop. A diversified manager with an established process may play a larger role. The allocation should reflect the job the manager performs and the risk it adds to the whole portfolio.
Familiarity is not diversification
Global equities deserve to be a mainstay because the opportunity set is global, not because Australia must underperform in any particular year. The discipline is to combine business quality with a sensible price and a reason for expectations to change. Geography shapes the risks, but it should not replace company analysis. Over a decade, the greater danger is not missing next year's winning country. It is allowing familiarity to determine the portfolio.
Jarrad Stuart is Portfolio Manager at Sharpbridge Funds Management, a Brisbane-based global equities boutique. The material in this article is general information only and does not take into account any person's objectives, financial situation or needs.